Stockholm Stock Exchange | Mid Cap
Camurus
+27.76%
Latest
+27.16%
3 months
Pareto SecuritiesBryan GarnierHandelsbanken Capital MarketsJefferies InternationalNordea MarketsDNBCarnegieJefferiesHandelsbankenDNB Markets

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia